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Introduction

36
Genome-wide association studies (GWASs) in the past decade have identified tens of thousands 37 of genetic variants associated with human complex traits (including common diseases) at a 38 stringent genome-wide significance level 1,2 . However, most of the trait-associated variants are 39 located in non-coding regions 3, 4 , and the causal variants as well as their functional roles in trait 40 etiology are largely unknown. One hypothesis is that the genetic variants affect the trait through 41 genetic regulation of gene expression 4 . Promoter-anchored chromatin interaction (PAI) 5,6 is a key 42 regulatory mechanism whereby non-coding genetic variants alter the activity of cis-regulatory 43 elements and subsequently regulate the expression levels of the target genes. Therefore, a 44 genome-wide map of PAIs is essential to understand transcriptional regulation and the genetic 45 regulatory mechanisms underpinning complex trait variation.
47
High-throughput experiments, such as Hi-C 7 and ChIA-PET (chromatin interaction analysis by 48 paired-end tag sequencing) 8 , have been developed to detect chromatin interactions by a massively 49 parallelized assay of ligated DNA fragments. Hi-C is a technique based on chromosome 50 conformation capture (3C) 9 to quantify genome-wide interactions between genomic loci that are 51 close in three-dimensional (3D) space. ChIA-PET is a method that combines ChIP-based methods 10 52 and 3C. The ChIA-PET method uses particular immune-precipitated proteins (e.g., transcription 53 factors) that can bind to specific genomic regions to identify protein-specific chromatin 54 interactions 8 . However, these high-throughput assays are currently not scalable to population-55 based cohorts with large sample sizes because of the complexity of generating a DNA library for 56 each individual (tissue or cell line) and the extremely high sequencing depth needed to achieve 57 high detection resolution 11 . On the other hand, recent technological advances have facilitated the 58 use of epigenomic marks to infer the chromatin state of a specific genomic locus and further to 59 predict the transcriptional activity of a particular gene 12, 13 . There have been increasing interests 60 in the use of epigenomic data (e.g., DNA methylation (DNAm) and/or histone modification) to 61 infer chromatin interactions [14] [15] [16] [17] . These analyses, however, rely on individual-level chromatin 62 accessibility data often only available in small samples 14, 16 , and it is not straightforward to use the 63 predicted chromatin interactions to interpret the variant-trait associations identified by GWAS.
65
In this study, we proposed an analytical approach to predict chromatin interaction by detecting 66 the association between DNAm levels of two CpG sites due to the same set of genetic variants (i.e., 67 pleiotropic association between DNAm sites). This can be achieved because if the methylation 68 levels (unmethylated, partly methylated or fully methylated) of a pair of relatively distal CpG sites 69 covary across individuals and such covariation is not (or at least not completely) caused by 70 environmental or experimental factors (evidenced by the sharing of a common set of causal 71 4 genetic variants in cis) ( Fig. 1a ) , it is very likely that the two genomic regions interact (having 72 contacts or functional links because of their close physical proximity in 3D space). Our analytical 73 approach was based on two recently developed methods, i.e., the summary-data-based Mendelian 74 randomization (SMR) test and the test for heterogeneity in dependent instruments (HEIDI) 18 , 75 which can be used in combination to detect pleiotropic associations between a molecular 76 phenotype (e.g. gene expression or DNA methylation) and a complex trait 18 or between two 77 molecular phenotypes 19 . The SMR and HEIDI approaches only require summary-level data from 78 DNA methylation quantitative trait locus (mQTL) studies, providing the flexibility of using mQTL 79 data from studies with large sample sizes to ensure efficient power. Since the proposed method is 80 based on cohort-based genetic data, it also allows us to integrate the predicted chromatin 81 interactions with GWAS results to understand the genetic regulatory mechanisms for complex 82 traits. In this study, we analyzed mQTL summary data from a meta-analysis of studies on 1,980 83 individuals with DNAm levels measured by Illumina 450K methylation arrays and SNP data from 84 SNP-array-based genotyping followed by imputation to the 1000 Genome Project (1KGP) 85 reference panels 19, 20 . For the ease of computation and to control the number of tests, we limited 86 the analysis to predict the interactions between promoters and genomic regions (of 87 approximately 4 Mb) centered around the focal promoters.
89
Results
90
Predicting promoter-anchored chromatin interactions using mQTL data 91 As described above, our underlying hypothesis was that if the variation between people in DNAm 92 levels of two relatively distal CpG sites are associated due to the same set of causal genetic variants 93 ( Fig. 1a) , then it is very likely that these two chromatin regions have contacts or functional links 94 because of their close physical proximity in 3D space. Hence, we set out to predict the promoter-95 anchored chromatin interactions (PAIs) from mQTL data. Our approach was to apply the SMR and 96 HEIDI approaches (both implemented in the SMR software tool) 18 to test for pleiotropic 97 associations between a DNAm site in the promoter region of a gene and all the other DNAm sites 98 within 2 Mb of the gene (excluding the DNAm sites in the same promoter region as the target 99 DNAm site) using mQTL summary data from peripheral blood samples ( Fig. 1, Fig. S1 and 6 gene locus did not overlap with the TADs identified by Hi-C from the Rao et al. study 24 (Fig. S3a) .
144
These predicted interactions, however, are very likely to be functional as indicated by our 145 subsequent analysis with GWAS and omics data (see below). Additionally, the predicted PAIs were 146 slightly enriched for chromatin loops identified by Hi-C 24 (1.49-fold, P < 0.001), although the 147 number of overlaps was small (m = 130).
149
Enrichment of the predicted PAIs in functional annotations
150
To investigate the functional role of the DNAm sites that showed significant interactions with the 151 DNAm sites in promoter regions (called promoter-interacting DNAm sites or PIDSs hereafter; i.e., 152 the "outcome" probes of the significant PAIs), we conducted an enrichment analysis of the PIDSs 153 (m = 14,361) in 14 main functional annotation categories derived from the REMC blood samples 154 (Methods) . Note that the PIDS of a PAI can also be located in the promoter region of another gene 155 (i.e., promoter-promoter interaction; Fig. 1b ). The fold-enrichment was computed as the 156 proportion of PIDSs in a functional category divided by that for the same number of variance-157 matched "control" probes randomly sampled from all the "outcome" probes used in the SMR 158 analysis. The standard deviation of the estimate of fold-enrichment was computed by repeatedly 159 sampling the control set 1,000 times. We found a significant enrichment of PIDSs in enhancers 160 (fold-enrichment=2.17 and Penrichment < 0.001), repressed Polycomb regions (fold-161 enrichment=1.50 and Penrichment < 0.001), primary DNase (fold-enrichment=1.37 and Penrichment < 162 0.001) and bivalent promoters (fold-enrichment=1.21 and Penrichment < 0.001) and a significant 163 underrepresentation in transcription starting sites (fold-enrichment=0.25 and Penrichment < 0.001), 164 quiescent regions (fold-enrichment=0.74 and Penrichment < 0.001), promoters around transcription 165 starting sites (fold-enrichment=0.83 and Penrichment < 0.001), and transcribed regions (fold-166 enrichment=0.86 and Penrichment < 0.001) in comparison with the "control" probes ( Fig. 3a and Fig.   167 3b). Although the PIDSs are underrepresented in promoters, it is of note that a large proportion 168 (~21%) of the predicted PAIs were promoter-promoter interactions (PmPmI), consistent with 169 the result from a previous study 5,27 that PmPmI were widespread and may play an important role 170 in transcriptional regulation.
172
Relevance of the predicted PAIs with gene expression
173
We then tested whether pairwise genes with significant PmPmI were enriched for co-expression.
174
We used gene expression data (measured by Transcript Per Kilobase Million mapped reads (TPM)) 175 from the blood samples of the Genotype-Tissue Expression (GTEx) project 28 and computed the 176 Pearson correlation of expression levels across individuals between pairwise genes (rP). We 177 randomly sampled the same number of distance-matched gene pairs (m = 2,236) from all the pairs, 178 whose promoters were tested for interaction in the PAI analysis, and repeated the sampling 1,000 7 times to generate a distribution of mean correlations of expression levels between a set of "control" 180 gene pairs. The mean correlation for the significant PmPmI gene pairs ( ̅ # ) was 0.375, significantly 181 (P < 0.001) higher than that computed from the control gene pairs (mean of ̅ # = 0.317) ( Fig. 3c ),
182
suggesting that pairwise genes with PmPmI are more likely to be co-expressed.
184
We also tested whether genes whose promoters were involved in significant PAI (called Pm-PAI 185 genes hereafter, Fig. 1) were expressed more actively than the same number of "control" genes 186 whose promoter DNAm sites were included in the SMR analysis. Similar to the analysis above, we 187 used the gene expression data (measured by TPM) from the blood samples of the GTEx project 188 and tested the significance of enrichment of Pm-PAI genes in different expression level groups.
189
We found that in comparison to the "control" genes, Pm-PAI genes were significantly 190 overrepresented (P < 0.001) among the group of genes with the highest expression levels and 191 significantly underrepresented (P < 0.001) among genes that were not actively expressed (median 192 TPM < 0.1) ( Fig. 3d and Methods), implicating the regulatory role of the PIDSs in transcription 193 and their asymmetric effects on gene expression.
195
Enrichment of eQTLs in the PIDS regions 196 We have shown that the PIDSs are located in regions enriched with regulatory elements (e.g., 197 enhancers) ( Fig. 3b ) and that the Pm-PAI genes tend to have higher expression levels ( Fig. 3d) .
198
We next investigated if genomic regions near PIDS are enriched for genetic variants associated 199 with expression levels of Pm-PAI genes using data from an expression quantitative trait locus 200 (eQTL) study in blood 29 . There were 11,204 independent cis-eQTLs at PeQTL < 5 × 10 −8 for 9,967 201 genes, among which 2,053 were Pm-PAI genes (Methods). We mapped cis-eQTLs to a 10 Kb 202 region centered around each PIDS (5 Kb on either side) and counted the number of cis-eQTLs 203 associated with expression levels of the corresponding Pm-PAI gene for each PIDS. There were 204 591 independent eQTLs located in the PIDS regions of the Pm-PAI genes, significantly higher than 205 (P < 0.001) that from a "control" sample (mean = 454), where the number of independent eQTL 206 was computed from the same number of 10 Kb regions around distance-matched pairs of DNAm 207 probes randomly sampled from the SMR "exposure" and "outcome" probes ( Fig. 4a) . These results 208 again imply the regulatory role of the PIDSs in transcription through eQTLs and provide evidence 209 supporting the functional role of the predicted PAIs.
211
There were examples where a cis-eQTL was located in a PIDS region predicted to interact with 212 the promoters of multiple genes. For instance, our result showed that a cis-eQTL was located in 213 an enhancer region that was predicted to interact with the promoters of three genes (i.e., ABCB9,
214
ARL6IP4, and MPHOSPH9) (Fig. S4) , and the predicted interactions were consistent with the TADs 215 8 identified by Hi-C from Rao et al. 24 (Fig. S3b) . Furthermore, the predicted interactions between 216 promoter regions of ARL6IP4 and MPHOSPH9 are consistent with the chromatin contact loops 217 identified by Hi-C in the the GM12878 cells 24 (Fig. S4) . The eQTL association signals were highly 218 consistent for the three genes, and the pattern was also consistent with the SNP association 219 signals for schizophrenia (SCZ) and years of education (EY) as shown in our previous work 19 , 220 suggesting a plausible mechanism whereby the SNP effects on SCZ and EY are mediated by the 221 expression levels of at least one of the three co-regulated genes through the interactions of the 222 enhancer and three promoters ( Fig. S4 ).
224
We have shown previously that the functional association between a DNAm site and a gene nearby PIDSs were the gene-associated DNAm sites identified in our previous study 19 , significantly higher 230 (P < 0.001) than that computed from the distance-matched control probe pairs (1.1%) described 231 above ( Fig. 4b) .
233
Replication of the predicted PAIs across tissues
234
To investigate the robustness of the predicted PAIs across tissues, we performed the PAI analysis 235 using brain mQTL data from the Religious Orders Study and Memory and Aging Project 236 (ROSMAP) 30 (n = 468). Of the 11,082 PAIs with PSMR < 1.69 × 10 −9 and PHEIDI > 0.01 in blood and 237 available in brain, 2,940 (26.5%) showed significant PAIs in brain after Bonferroni correction for 238 multiple testing (PSMR < 4.51 × 10 −6 and PHEIDI > 0.01). If we use a less stringent threshold for 239 replication, e.g., the nominal P value of 0.05, 66.31% of PAIs predicted in blood were replicated in 240 brain. Here, the replication rate is computed based on a p-value threshold, which is dependent of 241 the sample size of the replication data. Alternatively, we can estimate the correlation of PAI effects 242 (i.e., the effect of the exposure DNAm site on the outcome site of a predicted PAI) between brain 243 and blood using the rb method 31 . This method does not rely on a p-value threshold and accounts 244 for estimation errors in the estimated effects, which is therefore not dependent of the replication 245 sample size. The estimate of rb was 0.527 (SE = 0.0051) for 11,082 PAIs between brain and blood, 246 suggesting a relatively strong overlap in PAI between brain and blood.
248
It is of note that among the 2,940 blood PAIs replicated at PSMR < 4.51 × 10 −6 and PHEIDI > 0.01 in 249 brain, there were 268 PAIs for which the PAI effects in blood were in opposite directions to those 250 in brain ( Supplementary Table 1 ). For example, the estimated PAI effect between the SORT1 and 251 9 SYPL2 loci was 0.49 in blood and -0.86 in brain. This tissue-specific effect is supported by the 252 differences in gene expression correlation (correlation of expression levels between SORT1 and 253 SYPL2 was -0.07 in whole blood and -0.37 in brain frontal cortex; Pdifference = 0.0018) and the 254 chromatin state of the promoter of SYPL2 (bivalent promoter in blood and active promoter in 255 brain; Fig. S5 ) between brain and blood. Taken together, while there are tissue-specific PAIs, a 256 substantial proportion of the predicted PAIs in blood are consistent with those in brain.
258
Putative target genes of the disease-associated PIDSs
259
We have shown above the potential functional roles of the predicted PAIs in transcriptional 260 regulation. We then turned to ask how the predicted PAIs can be used to infer the genetic and 261 epigenetic regulatory mechanisms at the GWAS loci for complex traits and diseases. We have 262 previously reported 1,203 pleiotropic associations between 1,045 DNAm sites and 15 complex 263 traits and diseases by an integrative analysis of mQTL, eQTL and GWAS data using the SMR and 264 HEIDI approaches 19 . Of the 1,045 trait-associated DNAm sites, 601 (57.5%) sites were involved in 265 the predicted PAIs related to 299 Pm-PAI genes ( Supplementary Table 2 ). We first tested the variants affect the trait through genetic regulation of gene expression. One notable example was 277 a PIDS (cg00271210) in an enhancer region predicted to interact in 3D space with the promoter 278 regions of two genes (i.e., RNASET2 and RPS6KA2), the expression levels of both of which were 279 associated with ulcerative colitis (UC) and CD as reported in our previous study 19 (Fig. 5) . The 280 SNP-association signals were consistent across CD GWAS, eQTL, and mQTL studies, suggesting 281 that the genetic effect on CD is likely to be mediated through epigenetic regulation of gene 282 expression. Our predicted PAIs further implicated a plausible mechanism whereby the expression 283 levels of RNASET2 and RPS6KA2 are co-regulated through the interactions of their promoters with 284 a shared enhancer ( Fig. 5) , although only 41.5% of the predicted PAIs in this region overlapped 285 with the TADs identified by Hi-C from the Rao et al. study 24 (Fig. S3a) as mentioned above.
286
According to the functional annotation data derived from the REMC samples, it appears that this 287 10 shared enhancer is highly tissue-specific and present only in B cell and digestive system that are 288 closely relevant to CD (Fig. 5) . The over-expression of RNASET2 in spleen ( Fig. S6) is an additional 289 piece of evidence supporting the functional relevance of this gene to CD. Another interesting 290 example is the ATG16L1 locus ( Fig. S7) . We have shown previously that five DNAm sites are in 291 pleiotropic associations with CD and the expression level of ATG16L1 19 . Of these five DNAm sites, 292 three were in an enhancer region and predicted to interact in 3D space with two DNAm sites in 293 the promoter region of ATG16L1 (Fig. S7) , suggesting a plausible mechanism that the genetic 294 effect on CD at this locus is mediated by genetic and epigenetic regulation of the expression level 295 of ATG16L1 through promoter-enhancer interactions.
297
Discussion
298
We have presented an analytical approach on the basis of the recently developed SMR and HEIDI 299 methods to predict promoter-anchored chromatin interactions using mQTL summary data. The
300
proposed approach uses DNAm level of a CpG site in the promoter region of a gene as the bait to 301 detect its pleiotropic associations with DNAm levels of the other CpG sites ( Fig. 1) 
309
Using mQTL summary-level data from human peripheral blood (n = 1,980), we predicted 34,797 310 PAIs for the promoter regions of 4,617 genes. We showed that the predicted PAIs were enriched 311 in TADs detected by published Hi-C and PCHi-C assays and that the PIDS regions were enriched 312 with eQTLs of target genes. We also showed that the PIDSs were enriched in enhancers and that 313 the Pm-PAI genes tended to be more actively expressed than matched control genes. These results 314 demonstrate the functional relevance of the predicted PAIs to transcriptional regulation and the 315 feasibility of using data from genetic studies of chromatin status to infer three-dimensional 316 chromatin interactions. The proposed approach is applicable to data from genetic studies of other 317 chromatin features such as histone modification (i.e., hQTL) 33 or chromatin accessibility (caQTL) 34 .
318
The flexibility of the method also allowed us to analyse data from different tissues or cell types.
319
Using summary data from a brain mQTL study (n = 468), we replicated 26.5% of blood PAIs in 320 brain at a very stringent threshold (PSMR < 0.05 / m with m being the number of tests in the 321 replication set and PHEIDI > 0.01) and 66.31% at a less stringent threshold (PSMR < 0.05). Together 322 with an estimate of rb of 0.527 for the correlation of PAI effects between brain and blood, we 323 11 demonstrated a substantial overlap of the predicted PAIs between blood and brain, in line with 324 the finding from a recent study that cis-mQTLs are largely shared between brain and blood 31 . region of a gene as the "exposure" and tested its associations with the DNAm levels of other probes 390 ("outcomes") within 2 Mb of the exposure probe ( Fig. 1 and Fig. S1 ). Probe pairs in the same 391 promoter region were not included in the analysis. For a pair of probes in two different promoter 392 regions, the one with higher variance explained by its top associated cis-mQTL was used as the 393 exposure and the other one was used as the outcome. (Supplementary Note 1) . The simulation results showed that P values 409 from both SMR and HEIDI test were evenly distributed under the null model without inflation or 410 deflation (Fig. S8) To quantify the expression levels of genes whose promoters were involved in the predicted PAIs 473 (Pm-PAI genes), we used gene expression data (measured by Transcript Per Kilobase Million 474 mapped reads (TPM)) from blood samples of the Genotype-Tissue Expression (GTEx) project 28 .
475
We classified all the genes into two groups based on their expression levels in GTEx blood, i.e., 476 active and inactive (TPM < 0.1). For the active genes, we further divided them into four quartiles 477 based on their expression levels in GTEx blood, and counted the number of Pm-PAI genes in each 478 of the five groups. To generate the null distribution, we randomly sampled the same number of 479 "control" genes whose promoter DNAm sites were included in the SMR analysis, and repeated the 480 random sampling 1,000 times. We computed the number of Pm-PAI genes and "control" genes in The eQTL enrichment analysis was conducted using all the independent cis-eQTLs (m=11,204) 486 from CAGE 29 study. The independent cis-eQTLs were from SNP-probe associations (P < 5×10 −8 ) 487 after clumping analysis in PLINK 50 followed by a conditional and joint (COJO) analysis in GCTA 51 .
488
We only retained the cis-eQTLs whose target genes had at least a PIDS and mapped the cis-eQTL 489 to a 10 Kb region centred around each corresponding PIDS of a Pm-PAI gene. To assess the 490 significance of the enrichment, we generated a null distribution by mapping the cis-eQTLs to the 491 same number of "control" gene-DNAm pairs (strictly speaking, it is the bait DNAm probe in the 492 promoter of a gene together with another non-promoter DNAm probe) randomly sampled (with 493 1,000 repeats) from those included in the PAI analysis with the distance between a control pair 494 matched with that between a Pm-PAI gene and the corresponding PIDS. In addition, we have 495 identified a set of DNAm sites that showed pleiotropic associations with gene expressions in a 496 previous study 19 . We used the same approach as described above to test the significance of 
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The top plot shows -log10(P values) of SNPs from the GWAS meta-analysis (grey dots) for CD 44 .
697
Red diamonds and blue circles represent -log10(P values) from SMR tests for associations of gene 698 expression and DNAm probes with CD, respectively. Solid diamonds and circles are the probes not 699 rejected by the HEIDI test (PHEIDI>0.01). The second and third plots show -log10(P values) of SNP 700 associations for the expression levels of probe ILMN_1671565 (tagging RNASET2) and 
